期刊文献+

麦胚凝集素修饰延缓脂质体眼部消除 被引量:5

Modification by wheat germ agglutinin delays the ocular elimination of liposome
原文传递
导出
摘要 本文旨在探讨麦胚凝集素(wheat germ agglutinins,WGA)修饰的脂质体作为眼部药物递送载体的可行性。采用成膜水化法制备包载5-羧基荧光素(5-carboxyfluorescein,FAM)的脂质体(liposome loaded with FAM,LS/FAM),将巯基化的WGA经聚乙二醇桥联修饰于该脂质体表面(WGA-modified liposome loaded with FAM,WGA-LS/FAM)。测定WGA的巯基化程度,考察其修饰到脂质体表面后的生物活性,并对WGA-LS/FAM的理化性质和眼部生物黏附性能进行表征和评价。所得巯基化WGA每分子中含1.32个巯基。WGA-LS/FAM的平均粒径为(97.40±1.39)nm,多分散系数为0.23±0.01,FAM的包封率为(2.95±0.21)%,体外24 h的渗漏率约为4%。红细胞凝集实验表明,修饰到脂质体表面的WGA仍保持其糖蛋白结合活性。脂质体在大鼠眼部的消除过程符合一级动力学特征,WGA-LS/FAM的消除速率显著低于未经修饰的脂质体,表现出适合眼部给药的生物黏附特性。 The purpose of this study is to explore the feasibility of wheat germ agglutinin (WGA) modified liposome as a vehicle for ophthalmic administration. Liposome loaded with 5-carboxyfluorescein (FAM) was prepared by lipid film hydration method. WGA was thiolated and then conjugated to the surface of the liposome via polyethylene glycol linker to constitute the WGA-modified and FAM-loaded liposome (WGA-LS/FAM). The amount of thiol groups on each WGA molecule was determined, and the bioactivity of WGA was estimated after it was modified to the surface of liposome. The physical and chemical features of the WGA-modified liposome were characterized and the ocular bioadhesive performance was evaluated in rats. The result showed that each thiolated WGA molecule was conjugated with 1.32 thiol groups. WGA-LS/FAM had a mean size of (97.40 ± 1.39) nm, with a polydispersity index of 0.23 ± 0.01. The entrapment efficacy of FAM was about (2.95 ± 0.21) %, and only 4% of FAM leaked out of the liposome in 24 h. Erythrocyte agglutination test indicated that after modification WGA preserved the binding activity to glycoprotein. The in vivo ocular elimination of WGA-LS/FAM fitted first-order kinetics, and the elimination rate was significantly slower than that of the unmodified liposome, demonstrating WGA-modified liposome is bioadhesive and suitable for ophthalmic administration.
出处 《药学学报》 CAS CSCD 北大核心 2014年第4期543-549,共7页 Acta Pharmaceutica Sinica
基金 国家自然科学基金资助项目(81172994 81102402)
关键词 脂质体 生物黏附 麦胚凝集素 眼部给药 liposome bioadhesive wheat germ agglutinin ophthalmic administration
  • 相关文献

参考文献21

  • 1Whitcup SM. Recent advances in ocular therapeutics [J]. Int Ophthalmol Clin, 2006, 46:1-6.
  • 2Gaudana R, Jwala J, Boddu SH, et al. Recent perspectives in ocular drug delivery [J]. Pharm Res, 2009, 26:1197 -1216.
  • 3Shirasaki Y. Molecular design for enhancement of ocular penetration [J]. J Pharm Sci, 2008, 97: 2462-2496.
  • 4Urtti A. Challenges and obstacles of ocular pharmacokinetics and drug delivery [J]. Adv Drug Deliv Rev, 2006, 58:1131 1135.
  • 5Barar J, Javadzadeh AR, Omidi Y. Ocular novel drug delivery: impacts of membranes and barriers [J]. Expert Opin Drug Deliv, 2008, 5: 567-581.
  • 6Gaudana R, Ananthula HK, Parenky A, et al. Ocular drug delivery [J]. AAPS J, 2010, 12: 348-360.
  • 7Samad A, Sultana Y, Aqil M. Liposomal drug delivery systems: an update review [J]. Curr Drug Deliv, 2007, 4: 297-305.
  • 8Bu HZ, Gukasyan H J, Goulet L, et al. Ocular disposition, pharmacokinetics, efficacy and safety of nanoparticle-formulated ophthalmic drugs [J]. Curr Drug Metab, 2007, 8:91-107.
  • 9Vandervoort J, Ludwig A. Ocular drug delivery: nanomedicine applications [J]. Nanomedicine (Lond), 2007, 2:11 -21.
  • 10Shen Y, Tu JS. Preparation and ocular pharmacokinetics of ganciclovir liposomes [J]. AAPS J, 2007, 9:E371 -E377.

同被引文献35

引证文献5

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部